0
0
11/17/23 at 8:45pm
Organization
TCTMD
Author
Todd Neale
30 words
0
Comments
A REPRIEVE trial substudy shows 2 years of pitavastatin lessened noncalcified plaque volume and risk of plaque progression.
You are the first to view
https://www.tctmd.com/news/reductions-plaque-inflammation-appear-explain-statin-benefit-hiv
Create an account
or login to join the discussion